High-performance liquid chromatography (HPLC) determination of inosine, a potential biomarker for initial cardiac ischaemia, using isolated mouse hearts

Biomarkers

Volumn 11, Issue 5, 2006, Pages 449-459

  Farthing, D ^a   Xi, L ^a   Gehr, L ^b   Sica, D ^a   Larus, T ^a   Karnes, H T ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Cardiac oxidative stress; High performance liquid chromatography (HPLC); Inosine; Mouse cardiac ischaemia

Indexed keywords

BIOCHEMICAL MARKER; BUFFER; HYDROXYL RADICAL; INOSINE; METHANOL; TRIFLUOROACETIC ACID;

ANIMAL TISSUE; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIAGNOSTIC ERROR; EMERGENCY WARD; FLOW RATE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART VENTRICLE FUNCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL DISCHARGE; ISOLATED HEART; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PH MEASUREMENT; QUANTITATIVE ANALYSIS; THORAX PAIN; TIME; UNITED STATES;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FREE RADICALS; INOSINE; MICE; MICE, INBRED ICR; MYOCARDIAL ISCHEMIA; MYOCARDIUM; ORGAN SIZE; REPRODUCIBILITY OF RESULTS;

EID: 33748549640     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500600800074     Document Type: Article

References (19)

1. ADAM, Inc 2005. Heart attack and acute coronary syndrome(available at: http://adam.about.com/reports/000012_4.htm) (accessed on 27 May 2005).
2. Abd-Elfattah, AS and Higgins, RSD and Latifi, R and Merrell, RC. (2001) Targeting post-ischemic repurfusion injury: Scientific dream and clinical reality New Surgery, 1, pp. 41-51.
3. Beyerle, K. (2002) POC testing of cardiac markers enhances ED care Nursing Management, 33(9), pp. 37-39.
4. Bhagavan, NV and Lai, EM and Rios, PA and Yang, J and Ortega-Lopez, AM and Shinoda, H and Honda, SAA and Rios, CN and Sugiyama, CE and Ha, C. (2003) Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction Clinical Chemistry, 49(4), pp. 581-585.
5. Coudray, C and Favier, A. (2000) Determination of salicylate hydroxylation products as an in-vivo oxidative stress marker Free Radical Biology and Medicine, 29(11), pp. 1064-1070.
6. Dohm M. 2004. Origin and maintenance of the Hsd:ICR random-bred strain(available at: http://www2.hawaii.edu/approximately dohm/Phd/ OriginHsd.htm) (accessed on 7 November 2004).
7. Dorner, T and Rieder, A. (2004) Risk management of coronary heart disease-prevention Wiener Medizinische Wochenschrift, 154(11-12), pp. 257-265.
8. IUPAC. 1997, Fenton and Haber-Weiss reactions. IUPAC Compendium of Chemical Terminology 69: 1274-1277.
9. Lees K. 2000. Multiple marker test quickly identifies high-risk heart attack patients, study says. Heart Signs, Duke University News and Communications (available at: http://www.dukenews.duke.edu/2000/09/ heart901_print.htm) (accessed on 27 May 2005).
10. Luo, J and Jankowski, V and Gungar, N and Neumann, J and Schmitz, W and Zidek, W and Schluter, H and Jankowski, J. (2004) Endogenous diadensoine tetraphosphate, diadensoine pentaphosphate, and diadenosine hexaphosphate in human myocardial tissue Hypertension, 43(5), pp. 1055-1059.
11. Mei, DA and Gross, GJ and Nithipatikom, K. (1996) Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector Analytical Biochemistry, 238, pp. 34-39.
12. Morrow, DA and De Lemos, JA and Sabatine, MS and Antman, EM. (2003) The search for a biomarker of cardiac ischemia Clinical Chemistry, 49(4), pp. 537-539.
13. Naudziunas, A and Jankauskiene, L and Kalinauskiene, E and Pilvinis, V. (2005) Implementation of the patient education about cardiovascular risk factors into a daily routine of the Cardiology Unit of the hospital Preventive Medicine, 41(2), pp. 570-574.
14. Nelson, D and Cox, M.(2000) Lehninger principles of biochemistry 3rd ed. New York NY: Worth.
15. Okrainec, K and Banerjee, DK and Eisenburg, MJ. (2004) Coronary artery disease in the developing world American Heart Journal, 148(1), pp. 7-15.
16. Onodera, T and Ashraf, M. (1991) Detection of hydroxyl radicals in the post-ischemic reperfused heart using salicylate as a trapping agent Journal Molecular Cellular Cardiology, 23, pp. 365-370.
17. Tardif, J and Bourassa, M.(2000) Antioxidants and cardiovascular disease. Dordrecht: Kluwer.
18. Viegas, TX and Omura, GA and Stoltz, RR and Kisick, J. (2000) Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers Journal Clinical Pharmacology, 40, pp. 410-420.
19. Xi, L and Hess, ML and Kukreja, RC. (1998) Ischemic preconditioning in isolated perfused mouse heart: Reduction in infarct size without improvement of post-ischemic ventricular function Molecular and Cellular Biochemistry, 186, pp. 69-77.